Jackman Stephan 4
4 · Alzamend Neuro, Inc. · Filed Sep 20, 2022
Insider Transaction Report
Form 4
Jackman Stephan
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2022-09-19$1.23/sh+8,500$10,414→ 8,500 total
Footnotes (1)
- [F1]The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $1.2252. The range of purchase prices on the transaction date was $1.225 to $1.23 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.